Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shot up 12.5% during trading on Friday . The company traded as high as GBX 3.60 and last traded at GBX 3.60. 655,829 shares were traded during mid-day trading, a decline of 47% from the average session volume of 1,235,922 shares. The stock had previously closed at GBX 3.20.
Cizzle Biotechnology Price Performance
The stock’s 50-day moving average is GBX 2.24 and its two-hundred day moving average is GBX 1.80. The company has a market cap of £14.27 million, a P/E ratio of -21.18 and a beta of 0.07.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs
- 2 Ways to Play the Big Pharma Patent Cliff
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
